Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
CDCA5 promotes hepatocellular carcinoma progression by suppressing ferroptosis through PP2Ac/p53/STEAP3 signaling
Related
- PSAT1 integrates ferroptosis resistance and immune evasion to drive hepatocellular carcinoma progression
- Magnesium cantharidate suppresses hepatocellular carcinoma progression and modulates tumor-associated macrophage polarization: potential involvement of ERK1/2 signaling and de novo serine synthesis
- Palmatine Induces TNNT1 Ubiquitination and Degradation to Potentiate Ferroptosis Sensitivity in Hepatocellular Carcinoma
- Disrupting the cholesterol–mechanics axis enables ferroptosis and deep drug delivery in hepatocellular carcinoma
- CD36-Mediated Lipid Metabolic Reprogramming in Hepatocellular Carcinoma: Crosstalk With Immunity, Ferroptosis, and Therapeutic Resistance.
BibTeX
@article{wu2026cdca5,
title = {{CDCA5 promotes hepatocellular carcinoma progression by suppressing ferroptosis through PP2Ac/p53/STEAP3 signaling}},
author = {Di Wu and Haonan Zhou and Shiqi Liu and Haomin Wu and Yifan Jin and Ruilin Xing and Hongwei Yang and Gang Wu},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-74749-0},
url = {https://www.nature.com/articles/s41598-026-74749-0},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - CDCA5 promotes hepatocellular carcinoma progression by suppressing ferroptosis through PP2Ac/p53/STEAP3 signaling
AU - Di Wu
AU - Haonan Zhou
AU - Shiqi Liu
AU - Haomin Wu
AU - Yifan Jin
AU - Ruilin Xing
AU - Hongwei Yang
AU - Gang Wu
PY - 2026
DA - 2026/10/11
JO - Scientific Reports
DO - 10.1038/s41598-026-74749-0
UR - https://www.nature.com/articles/s41598-026-74749-0
SN - 2045-2322
ER -